BAGSVAERD, DENMARK--(Marketwire - April 28, 2011) -
Organic sales growth of 15% driven by Victoza®, NovoRapid® and
Levemir®
Company Announcement no 25 2011: http://hugin.info/2013/R/1509892/444770.pdf
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Thomson Reuters ONE
[HUG#1509892]
Contacts for further information
Media:
Mike Rulis
Tel: (+45) 4442 3573
Email Contact
In North America
Ken Inchausti
Tel: (+1) 609 786 8316
Email Contact
Investors:
Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact
Jannick Lindegaard
Tel: (+45) 4442 4765
Email Contact
Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact
In North America
Hans Rommer
Tel: (+1) 609 216 4834
Email Contact